Related Experiment Video
Updated: Jul 18, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Antioxidant effects of metronidazole in colonic tissue
M A Pélissier1, P Marteau, P Pochart
1Laboratoire de Biologie, EA-3199, Conservatoire National des Arts et Métiers, 2 rue Conté, 75003 Paris, France. pelissie@cnam.fr
Abstract:
Reactive oxygen species, primarily generated in the mitochondria, contribute to tissue injury in inflammatory bowel diseases. The efficacy of metronidazole (MTZ) in some situations of inflammatory bowel disease may result not only from its antibiotic effect, but also from an antioxidant effect. We evaluated, under physiologic conditions, the antioxidant potential of MTZ on the biomarkers of oxidative damage to proteins (protein carbonyls), lipids (malondialdehyde), and the levels of antioxidant defense (glutathione) in the small bowel, large bowel, and liver of control and MTZ-treated rats. Basal levels of protein carbonyls and malondialdehyde were significantly higher in the colon compared with those in the small intestine, whereas glutathione levels were quite similar along the bowel. MTZ reduced significantly the colonic oxidative damage to proteins without any side effect in the liver. This is the first evidence of an antioxidant effect of MTZ on oxidative protein damage in the colon under physiologic conditions.
Insights
Metronidazole (MTZ) demonstrates antioxidant effects by reducing oxidative protein damage in the colon. This study provides the first evidence of MTZ
Area of Science:
- Biochemistry
- Pharmacology
- Gastroenterology
Background:
- Reactive oxygen species (ROS) contribute to tissue injury in inflammatory bowel diseases (IBD).
- Metronidazole (MTZ) may possess antioxidant properties beyond its antibiotic effects in IBD treatment.
- Oxidative stress biomarkers include protein carbonyls, malondialdehyde, and glutathione levels.
Purpose of the Study:
- To evaluate the antioxidant potential of metronidazole (MTZ) on oxidative damage biomarkers in rat gastrointestinal tissues and liver.
- To investigate the effect of MTZ on protein carbonyls, malondialdehyde, and glutathione levels under physiological conditions.
Main Methods:
- Controlled study involving MTZ-treated and control rats.
- Measurement of protein carbonyls, malondialdehyde, and glutathione levels in the small intestine, large intestine (colon), and liver.
- Assessment of oxidative damage and antioxidant defense under physiological conditions.
Main Results:
- Basal levels of protein carbonyls and malondialdehyde were significantly higher in the colon than in the small intestine.
- MTZ significantly reduced oxidative protein damage (protein carbonyls) in the colon.
- MTZ did not cause any adverse side effects on liver biomarkers.
Conclusions:
- Metronidazole exhibits a significant antioxidant effect on oxidative protein damage in the colon.
- This study provides the first evidence of MTZ's antioxidant activity on colonic protein damage under physiological conditions.
- MTZ's efficacy in certain IBD cases may be partly attributed to its antioxidant properties.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
